Advances in clinical and molecular genetics studies on argininemia.
- Author:
Tong-Fei WU
1
;
Yan-Ling YANG
Author Information
1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China. organic acid@126.com.
- Publication Type:Journal Article
- MeSH:
Arginase;
genetics;
Humans;
Hyperargininemia;
diagnosis;
genetics;
therapy;
Molecular Biology;
Prognosis
- From:
Chinese Journal of Contemporary Pediatrics
2013;15(11):954-959
- CountryChina
- Language:Chinese
-
Abstract:
Argininemia is a rare, autosomal recessive, metabolic disorder caused by an hereditary deficiency of hepatocytes arginase due to ARG1 gene defect. Arginase is the final enzyme in the urea cycle, catalyzing the hydrolysis of arginine to ornithine and urea. Research advances in the clinical manifestations, diagnosis, treatment, prenatal diagnosis and genetics of argininemia were reviewed in this paper. The clinical manifestations of patients with argininemia are complicated and nonspecific so that clinical diagnosis is usually difficult and delayed. Progressive spastic tetraplegia, seizures and cerebella atrophy are common clinical features of the disease. Blood amino acids analysis, arginase assay and ARG1 gene analysis are important to the diagnosis of argininemia. Early diagnosis and a protein-restricted diet with citrulline and benzoate supplements can contribute a lot to improve patient prognosis. With the application of liquid chromatography-tandem mass spectrometry in selective screening and newborn screening for inborn errors of metabolism, an ever-increasing number of patients with argininemia are detected at the asymptomatic or early stages.
